Literature DB >> 16231338

Stroop interference task and single-photon emission tomography in anorexia: a preliminary report.

Antonio Maria Ferro1, Andrea Brugnolo, Caterina De Leo, Barbara Dessi, Nicola Girtler, Silvia Morbelli, Flavio Nobili, Davide Sebastiano Rossi, Maria Falchero, Giovanni Murialdo, Paolo M Rossini, Claudio Babiloni, Rodolfo Schizzi, Riccardo Padolecchia, Guido Rodriguez.   

Abstract

OBJECTIVE: The aim of this preliminary study was to investigate the physiologic substrate of executive function in anorexia nervosa (AN) by assessing the relation between brain perfusion and Stroop interference task (SIT).
METHOD: The classical SIT test and brain single-photon emission tomography (SPET) were evaluated in 16 AN females (mean age = 23.69 +/- 8.68 years; mean body mass index [BMI] = 16.19 +/- 1.53 kg/m2). The relation between the two examinations was searched by statistical parametric mapping (SPM 99) with a height threshold of p = .001.
RESULTS: An abnormally low or a borderline SIT value was found in 25% of patients. A significant correlation between the SIT score and brain perfusion was found in the superior frontal gyrus of both hemispheres (Brodmann's area [BA] 6 in both hemispheres and BA 8 in the right hemisphere). No correlation was found in the anterior cingulate gyrus.
CONCLUSION: BA 6 and BA 8 and the anterior cingulate are believed to be the basis of both error detection and immediate correction. Activity of BA 6 and BA 8 reflects this executive task in AN patients as well, whereas the lack of correlation in the anterior cingulate may suggest its blunted activity in AN patients, similarly to what is shown in other conditions characterized by impaired executive function, such as patients with depression, patients with schizophrenia, and abstinent drug abusers. However, these findings should still be quoted as preliminary, given some limitations of the study design, such as the lack of a control group, and the unfeasibility of controlling some relevant confounding variables, such as psychiatric comorbidity, medication, and the time interval between examinations, mainly deriving from the relatively few patients studied. Copyright 2005 by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16231338     DOI: 10.1002/eat.20203

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  5 in total

1.  An updated Italian normative dataset for the Stroop color word test (SCWT).

Authors:  A Brugnolo; F De Carli; J Accardo; M Amore; L E Bosia; C Bruzzaniti; S F Cappa; L Cocito; G Colazzo; M Ferrara; L Ghio; E Magi; G L Mancardi; F Nobili; M Pardini; R Rissotto; C Serrati; N Girtler
Journal:  Neurol Sci       Date:  2015-11-30       Impact factor: 3.307

2.  Cerebral blood volume changes in patients with eating disorders during word fluency: a preliminary study using multi-channel near infrared spectroscopy.

Authors:  T Uehara; M Fukuda; M Suda; M Ito; T Suto; M Kameyama; Y Yamagishi; M Mikuni
Journal:  Eat Weight Disord       Date:  2007-12       Impact factor: 4.652

3.  Predicting clinical outcome using brain activation associated with set-shifting and central coherence skills in Anorexia Nervosa.

Authors:  Amy S Garrett; James Lock; Nandini Datta; Judy Beenhaker; Shelli R Kesler; Allan L Reiss
Journal:  J Psychiatr Res       Date:  2014-07-03       Impact factor: 4.791

4.  Altered BOLD response during inhibitory and error processing in adolescents with anorexia nervosa.

Authors:  Christina Wierenga; Amanda Bischoff-Grethe; A James Melrose; Emily Grenesko-Stevens; Zoë Irvine; Angela Wagner; Alan Simmons; Scott Matthews; Wai-Ying Wendy Yau; Christine Fennema-Notestine; Walter H Kaye
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

Review 5.  Are Extremes of Consumption in Eating Disorders Related to an Altered Balance between Reward and Inhibition?

Authors:  Christina E Wierenga; Alice Ely; Amanda Bischoff-Grethe; Ursula F Bailer; Alan N Simmons; Walter H Kaye
Journal:  Front Behav Neurosci       Date:  2014-12-09       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.